Tag: Cancer: Pancreatic
Model Using Routine Clinical Data May Predict Pancreatic Cancer Risk
Findings show promise following diagnosis of impaired fasting glucose
Model Using Routine Clinical Data May Predict Pancreatic Cancer Risk
Findings show promise following diagnosis of impaired fasting glucose
New Symptoms ID’d That May Indicate Pancreatic Cancer
Additional symptoms can be used to update QCancer, a risk prediction model that helps physicians identify patients at high risk for cancer
2000 to 2018 Saw Increase in Incidence of Pancreatic Cancer
Incidence increased for men and women; relative increase greater for women versus men aged younger than 55 years
More Frequent Alcohol Consumption Ups Risk for GI Cancers
Amount of alcohol consumed in each occasion seems to be a less important risk factor
Minorities, Women Underrepresented in Pancreatic Cancer Trials
84.7 percent of patients in clinical trials were White and 54.8 percent were men; underrepresentation seen in trials of nearly all phases
Mortality Risk Up for Fragmented Care After Complex Cancer Surgery
Mortality higher for patients readmitted to outside hospital rather than index hospital after hepatopancreatobiliary or gastric cancer surgery
Margin-Positive Surgery Still Beneficial in Pancreatic Cancer
Survival benefit seen for surgery, even with R1/R2 resection margins compared with chemotherapy alone for stage II pancreatic cancer
Perioperative Chemo Feasible for Resectable Pancreatic Cancer
Phase 2 randomized trial revealed similar overall survival for two active regimens compared with adjuvant therapy
Opioid Use May Contribute to Risk for Pancreatic Cancer
At the state level, opioid death rate at four years prior predicted the initial incidence of pancreatic cancer